Navigation Links
Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
Date:5/21/2012

CHAPEL HILL, N.C., May 21, 2012 /PRNewswire/ -- Savvy vice presidents and directors across all pharmaceutical commercial functions are searching now for best-in-class organizational structures, critical activities, proven processes, and investment benchmarks that ensure sustained growth across global markets.

"In today's increasingly competitive health care environment, global leaders and managers need to have analysis from across the worldwide marketplace," says Best Practices CEO, Chris Bogan. "Information from one country or region is not enough."

To support pharmaceutical leaders tasked with global oversight of structuring, resourcing, and strategic planning, Best Practices, LLC launches Global Management Navigator within the Wizards & Analytics Search (http://www3.best-in-class.com/rw16.htm).

"The Global Management Navigator puts benchmarking research, insights and analysis from a worldwide perspective into leaders' hands and supports evidence-based and informed decision-making," Bogan explains. The new Wizard searches the Best Practice Database for global benchmarks in a specified function, group, process or role.

For example, one often-searched health care area is "medical science liaisons," a highly knowledgeable group who provide critical medical information to the practicing community on behalf of the companies that manufacture new medicines and/or devices. To demonstrate the power of the new search Wizards in the Best Practice Database Global Management Navigator using the popular search term "medical science liaisons," simply:

How to Use the Global Management Navigator:

  • Visit the Global Management Navigator at http://www3.best-in-class.com/rw16.htm.   
  • In the fifth text box, insert the evolving role of "medical science liaisons" in quotations.
  • Click the "Search Now" button to the right of the text box.
  • Review the list of relevant documents in the Best Practice Database.
  • Click on the document titles of most interest, including the first hit "Medical Science Liaison Services Excellence: Managing Internal Activities and Providing Oversight." (http://www3.best-in-class.com/rr1155.htm)

Best Practice Database documents include benchmarks and insights gathered from quantitative and qualitative primary research with executives at pharmaceutical companies. Subscribers to the Best Practice Database have access to these primary research results to make informed decisions in their functional areas. Within the documents, charts, graphs, and process maps enable executives to assess resource levels, responsibility scope, and performance metrics of their function.

For more information on the Global Management Navigator or how to determine if your group is among the low performers or the best-in-class performers, contact us at 919.403.0251 or at bestpractices@best-in-class.com.  

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide.

Best Practices, LLC's clients include the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our reports, database, and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/27/2016)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... second quarter ended March 26, 2016.  GAAP diluted ... and non-GAAP diluted EPS of $0.47 increased 14.6%.  ... reported basis, and 6.3% on a constant currency ... quarter, highlighted by 14.6% growth in non-GAAP EPS," ...
(Date:4/27/2016)... York , April 27, 2016 ... report titled, "Skincare Devices Market - Global Industry Analysis, ... According to the report, the global skincare devices market ... is anticipated to expand at a CAGR of 10.1% ... in 2023. Browse the full Skincare Devices Market ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart ... at its new location in the Exchange Furniture Mall at 112 Vilseck Road in ... 50-inch Samsung Smart TV. Plus attendees will have the opportunity to meet general dentists ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification Program ... to announce the launch of the GFCP Scoop in response to ... purpose of the GFCP Scoop site is to keep the gluten-free ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
Breaking Medicine News(10 mins):